All posts by: Michael Zand

About Michael Zand

Worry Less About Peanut Allergies with Sublingual Immunotherapy – Mainline Today

Continue reading

2018-02-12 NEWS

Worry Less About Peanut Allergies with Sublingual Immunotherapy
Mainline Today
The board certified allergists at Allergy & Asthma Specialists are using the latest treatment for peanut allergies: sublingual immunotherapy (SLIT). The treatment, used for many other allergies, works in the long term by reducing an individual’s

Continue reading

2018-02-12 NEWS

GlobeNewswire (press release)

CRISPR Therapeutics’ Lundberg Steps Down as Chief Scientific Officer
Xconomy
Bill Lundberg is leaving his position as chief scientific officer of CRISPR Therapeutics (NASDAQ: CRSP). CRISPR Therapeutics, which has operations in Switzerland and Cambridge, MA, said that Lundberg will continue as an advisor to the company and he is
CRISPR Therapeutics Announces Transition of Bill Lundberg, MDGlobeNewswire (press release)
Why Crispr Therapeutics AG Stock Bolted Higher in JanuaryMotley Fool
What’s CRISPR Therapeutics AG (CRSP) Upside After Today’s Big Increase?BZ Weekly
Post Analyst –Dispatch Tribunal –Post Registrar –SEC.gov
all 70 news articles »
Continue reading

2018-02-12 NEWS

Xconomy

Execs Talk Hurdles As Immunotherapy Combos, CAR-T Launches Progress
Xconomy
With multiple products on the market and many more coming, it’s easy to think that cancer immunotherapy has arrived. In reality, however, we’ve only just begun to figure out how to coax the immune system into killing cancer. That’s why a mad dash is on

Continue reading

2018-02-12 NEWS

Targeted Oncology

Expert Discusses the Potential Role of Immunotherapy in Ovarian Cancer
Targeted Oncology
… survival in ovarian cancer? What are the best combinations and when should we use them? When do you get the best benefit for patients? We just don’t know yet, but there are many studies that are open and the accrual to them has been tremendous. Our

and more »